42
Views
0
CrossRef citations to date
0
Altmetric
Articles

Frequency of Myoclonus and its Countermeasures in Terminally Ill Patients with Cancer: A Single-Center Retrospective Study

ORCID Icon, , , , , , & show all
Pages 117-122 | Received 16 Nov 2023, Accepted 13 Apr 2024, Published online: 09 May 2024

References

  • Mercadante S. Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain. 1998;74(1):5–9. doi:10.1016/S0304-3959(97)00090-0.
  • Caviness JN. Myoclonus. Mayo Clin Proc. 1996;71(7):679–88. doi:10.1016/S0025-6196(11)63006-1.
  • Kojovic M, Cordivari C, Bhatia K. Myoclonic disorders: a practical approach for diagnosis and treatment. Ther Adv Neurol Disord. 2011;4(1):47–62. doi:10.1177/1756285610395653.
  • Potter JM, Reid DB, Shaw RJ, Hackett P, Hickman PE. Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. BMJ. 1989;299(6692):150–3. doi:10.1136/bmj.299.6692.150.
  • Nishijima K, Kizawa Y, Yamauchi T, Odagiri T, Ito T, Kaneishi K, Shimizu K, Morita T, Mori M. Prevalence and associated factors of orphan symptoms in advanced cancer patients: a multicenter observational study. Support Care Cancer. 2021;29(9):5537–47. doi:10.1007/s00520-021-06144-6.
  • Lim K, Nguyen NN, Qian Y, Williams JL, Lui DD, Bruera E, Yennurajalingam S. Frequency, outcomes, and associated factors for opioid-induced neurotoxicity in patients with advanced cancer receiving opioids in inpatient palliative care. J Palliat Med. 2018;21(12):1698–704. doi:10.1089/jpm.2018.0169.
  • Hagen N, Swanson R. Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies. J Pain Symptom Manage. 1997;14(1):51–8. doi:10.1016/S0885-3924(97)00001-8.
  • de Conno F, Caraceni A, Martini C, Spoldi E, Salvetti M, Ventafridda V. Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain. 1991;47(3):337–9. doi:10.1016/0304-3959(91)90225-M.
  • McCann S, Yaksh TL, von Gunten CF. Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: a pilot study. J Opioid Manag. 2010;6(2):87–94. doi:10.5055/jom.2010.0008.
  • Frucht SJ, Leurgans SE, Hallett M, Fahn S. The Unified Myoclonus Rating Scale. Adv Neurol. 2002;89:361–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.